Literature DB >> 23097307

Multimodality image fusion to guide peripheral artery chronic total arterial occlusion recanalization in a swine carotid artery occlusion model: unblinding the interventionalist.

Andrew J Klein1, Michael T Tomkowiak, Karl K Vigen, Timothy A Hacker, Michael A Speidel, Michael S Vanlysel, Nehal Shah, Amish N Raval.   

Abstract

OBJECTIVES: To demonstrate the feasibility of magnetic resonance imaging (MRI) to X-ray fluoroscopy (XRF) image fusion to guide peripheral artery chronic total occlusion (CTO) recanalization.
BACKGROUND: Endovascular peripheral artery CTO revascularization is minimally invasive, but challenging, because the occlusion is poorly visualized under XRF. Devices may steer out of the artery, which can lead to severe perforation. Merging preacquired MRI of the CTO to the live XRF display may permit upfront use of aggressive devices and improve procedural outcomes.
METHODS: Swine carotid artery CTOs were created using a balloon injury model. Up to 8 weeks later, MRI of the carotid arteries was acquired and segmented to create three-dimensional surface models, which were then registered onto live XRF. CTO recanalization was performed using incrementally aggressive CTO devices (group A) or an upfront aggressive directed laser approach (group B). Procedural success was defined as luminal or subintimal device position without severe perforation.
RESULTS: In this swine model, MRI to XRF fusion guidance resulted in a procedural success of 57% in group A and 100% in group B, which compared favorably to 33% using XRF alone. Fluoroscopy time was significantly less for group B (8.5 ± 2.6 min) compared to group A (48.7 ± 23.9 min), P < 0.01. Contrast dose used was similar between groups A and B.
CONCLUSIONS: MRI to XRF fusion-guided peripheral artery CTO recanalization is feasible. Multimodality image fusion may permit upfront use of aggressive CTO devices with improved procedural outcomes compared to XRF-guided procedures.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 23097307      PMCID: PMC3518624          DOI: 10.1002/ccd.24391

Source DB:  PubMed          Journal:  Catheter Cardiovasc Interv        ISSN: 1522-1946            Impact factor:   2.692


  33 in total

1.  "Wireless" laser recanalization of chronic total coronary occlusions.

Authors:  E C Perin; R Sarmento-Leite; G V Silva; M D Rogers; O Topaz
Journal:  J Invasive Cardiol       Date:  2001-05       Impact factor: 2.022

2.  Practical use of duplex echo-guided recanalization of chronic total occlusion in the iliac artery.

Authors:  Osami Kawarada; Yoshiaki Yokoi; Kazushi Takemoto
Journal:  J Vasc Surg       Date:  2010-06-22       Impact factor: 4.268

3.  Exertional leg symptoms other than intermittent claudication are common in peripheral arterial disease.

Authors:  M M McDermott; S Mehta; P Greenland
Journal:  Arch Intern Med       Date:  1999-02-22

4.  Recanalisation of femoro-popliteal occlusions: improving success rate by subintimal recanalisation.

Authors:  A Bolia; J Brennan; P R Bell
Journal:  Clin Radiol       Date:  1989-05       Impact factor: 2.350

5.  Chronic total occlusions in the superficial femoral artery: a novel strategy using a 1.5 mm J-tip hydrophilic guidewire with an over-the-wire balloon catheter under ultrasound guidance.

Authors:  Osami Kawarada; Yoshiaki Yokoi; Nobuyuki Morioka; Shinji Nakata; Kazushi Takemoto
Journal:  Catheter Cardiovasc Interv       Date:  2005-06       Impact factor: 2.692

Review 6.  Magnetic resonance angiography.

Authors:  M J Graves
Journal:  Br J Radiol       Date:  1997-01       Impact factor: 3.039

7.  Peripheral arterial disease detection, awareness, and treatment in primary care.

Authors:  A T Hirsch; M H Criqui; D Treat-Jacobson; J G Regensteiner; M A Creager; J W Olin; S H Krook; D B Hunninghake; A J Comerota; M E Walsh; M M McDermott; W R Hiatt
Journal:  JAMA       Date:  2001-09-19       Impact factor: 56.272

Review 8.  Excimer laser assisted angioplasty for the treatment of critical limb ischemia.

Authors:  J R Laird; C Reiser; G Biamino; T Zeller
Journal:  J Cardiovasc Surg (Torino)       Date:  2004-06       Impact factor: 1.888

9.  Simultaneous antegrade and retrograde access for subintimal recanalization of peripheral arterial occlusion.

Authors:  David J Spinosa; Daniel A Leung; Nancy L Harthun; Dorothy L Cage; J Fritz Angle; Klaus D Hagspiel; Alan H Matsumoto
Journal:  J Vasc Interv Radiol       Date:  2003-11       Impact factor: 3.464

10.  High prevalence of peripheral arterial disease and co-morbidity in 6880 primary care patients: cross-sectional study.

Authors:  Curt Diehm; Alexander Schuster; Jens R Allenberg; Harald Darius; Roman Haberl; Stefan Lange; David Pittrow; Berndt von Stritzky; Gerhart Tepohl; Hans-Joachim Trampisch
Journal:  Atherosclerosis       Date:  2004-01       Impact factor: 5.162

View more
  4 in total

Review 1.  Update on New Tools for Three-dimensional Navigation in Endovascular Procedures.

Authors:  Jos C van den Berg
Journal:  Aorta (Stamford)       Date:  2014-12-01

2.  Fusion Image Guidance for Supra-Aortic Vessel Catheterization in Neurointerventions: A Feasibility Study.

Authors:  A Feddal; S Escalard; F Delvoye; R Fahed; J P Desilles; K Zuber; H Redjem; J S Savatovsky; G Ciccio; S Smajda; M Ben Maacha; M Mazighi; M Piotin; R Blanc
Journal:  AJNR Am J Neuroradiol       Date:  2020-08-20       Impact factor: 3.825

3.  A hybrid image fusion system for endovascular interventions of peripheral artery disease.

Authors:  Florent Lalys; Ketty Favre; Alexandre Villena; Vincent Durrmann; Mathieu Colleaux; Antoine Lucas; Adrien Kaladji
Journal:  Int J Comput Assist Radiol Surg       Date:  2018-03-16       Impact factor: 2.924

4.  CBCT-based 3D MRA and angiographic image fusion and MRA image navigation for neuro interventions.

Authors:  Qiang Zhang; Zhiqiang Zhang; Jiakang Yang; Qi Sun; Yongchun Luo; Tonghui Shan; Hao Zhang; Jingfeng Han; Chunyang Liang; Wenlong Pan; Chuanqi Gu; Gengsheng Mao; Ruxiang Xu
Journal:  Medicine (Baltimore)       Date:  2016-08       Impact factor: 1.889

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.